Mavacamten: A Game-Changer for Teens with Heart Obstruction from Hypertrophic Cardiomyopathy #USA #Philadelphia #Children's_Hospital #Hypertrophic_Cardiomyopathy #Mavacamten
For decades, we’ve treated HCM with beta-blockers and calcium channel blockers—drugs that manage symptoms but don’t touch the underlying mechanics.
doi.org/10.2174/0118715257283752240325082733
#WeiPublications #Cardiology #HCM #Mavacamten #MedSky #HeartFailure #Camzyos #Pharmacology #FOAMed
From #ESCCongress2025 - Prof. Milind Desai takes us through the key findings of the ODYSSEY-HCM study of #mavacamten in people with symptomatic nonobstructive hypertrophic #cardiomyopathy.
Watch the full interview here 👉 buff.ly/An0NdBI
#CardioSky
The third slide from the August 2025 issue of Journal Watch, titled "Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM." For a more screenreader friendly version, the full issue PDF is at https://www.ishlt.org/docs/default-source/journal-watch/2025-08-journalwatch-cardiology.pdf.
In last month's #ISHLTJournalWatch, #BhanuRamachandran reviews a study led by Milind Y. Desai on the use of #Mavacamten in patients with obstructive hypertrophic #cardiomyopathy ( #oHCM ). Can Mavacamten allow clinicians to defer or avoid SRT use in these patients?
#ISHLT #CardioSky #TransplantSky
Hi tthanks for replying. I'm still not on #Mavacamten I recently had an Echocardio to prepare for it. I will see the Cardiologist in a few weeks to talk about it. I am hesitant to take more drugs unless I have to so I want to ask if I'm really at the point where I need it. #HCM @bgrrl.bsky.social